Catheter Precision (VTAK) Notes Payables (2020 - 2026)

Catheter Precision (VTAK) has reported Notes Payables for 6 consecutive years, with $5.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Notes Payables rose 246.13% year-over-year to $5.2 million in Q2 2026; TTM through Jun 2026 was $5.2 million, a 246.13% increase from a year earlier, with the FY2024 full-year figure at $177000.0, down 3.8% from the prior year.
• Notes Payables was $5.2 million for Q2 2026 at Catheter Precision, down from $6.5 million in the prior quarter.
• Over five years, Notes Payables peaked at $6.5 million in Q1 2026 and troughed at $177000.0 in Q4 2024.
• A 4-year average of $2.4 million and a median of $1.5 million in 2025 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables retreated 3.8% in 2024 and jumped 336.0% in 2026, its largest moves.
• Over 4 years, Notes Payables stood at $184000.0 in 2023, then retreated by 3.8% to $177000.0 in 2024, then surged by 858.19% to $1.7 million in 2025, then soared by 206.13% to $5.2 million in 2026.
• The last three Notes Payables figures came in at $5.2 million (Q2 2026), $6.5 million (Q1 2026), and $1.7 million (Q3 2025), per Business Quant data.